Luigi Sebastiano Battaglia | brain disease targeting | Best Researcher Award

Prof. Luigi Sebastiano Battaglia | brain disease targeting | Best Researcher Award

Associate Professor, University of Turin, Italy

Luigi Sebastiano Battaglia is an Associate Professor in Pharmaceutical Technology at the University of Turin, where he has made significant contributions to the field of pharmaceutical science. His work focuses on innovative drug delivery systems, particularly using solid lipid nanoparticles (SLNs) and nanoemulsions. With a PhD in Drug Science from the University of Turin, Luigi has built a successful career in both academia and industry. He has been involved in numerous research projects aimed at advancing the treatment of brain diseases, including gliomas and neurodegenerative conditions, through nanotechnology. Luigi has published extensively in top-tier journals and holds multiple patents for his groundbreaking work. He collaborates with several prestigious institutions and is a recognized expert in drug targeting and delivery systems.

Profile

Education 

Luigi Sebastiano Battaglia completed his degree in Pharmacy at the University of Turin in 2002. He continued his academic journey with a PhD in Drug Science from the same institution in 2009. Over the years, he has held several academic roles at the University of Turin, including Research Associate, Assistant Professor, and Tenure-track Assistant Professor, before becoming an Associate Professor in Pharmaceutical Technology in 2020. His academic training has laid the foundation for his pioneering research in pharmaceutical technology, drug delivery, and nanomedicine. Battaglia has actively engaged in national and international collaborations, further enhancing his knowledge and expertise in the field.

Experience

Luigi Battaglia has more than two decades of experience in pharmaceutical technology and nanomedicine. He started his career as a Research Associate in the Department of Drug Science and Technology at the University of Turin, where he worked from 2006 to 2012. In 2012, he became an Assistant Professor at the Faculty of Pharmacy, later transitioning to a Tenure-track position at the Department of Drug Science and Technology. Since 2020, Luigi has been serving as an Associate Professor. Throughout his career, he has led several significant research projects, securing funding from various national and European sources. He has published over 70 articles in top scientific journals and is the author of numerous book chapters and patents. Luigi’s consultancy work with companies such as R BioTransfer further demonstrates his expertise in applying scientific knowledge to real-world challenges, particularly in cancer treatment and brain disease therapies.

Research Focus

Luigi Sebastiano Battaglia’s research focuses on the development of innovative drug delivery systems, with a particular emphasis on solid lipid nanoparticles (SLNs) and nanoemulsions. His work aims to address major challenges in the treatment of brain diseases, including gliomas, neurodegenerative disorders, and cerebrovascular conditions. Luigi has pioneered the preparation of ultrasmall SLNs and the functionalization of nanoemulsions with cell membrane fragments, allowing for more targeted and efficient drug delivery. His research also explores surface modifications of nanocarriers to enhance the transport of biologically active compounds across biological barriers such as the blood-brain barrier. A significant part of his research is dedicated to overcoming obstacles in drug targeting, particularly for cancer therapies. Through his innovative approach, Luigi aims to improve the efficacy and safety of drug treatments for various neurological conditions and disorders.

Publication Top Notes

  • Green Solid Lipid Nanoparticles by Coacervation of Fatty Acids: An Innovative Cosmetic Ingredient for the Delivery of Anti-Age Compounds Through the Skin 🌱💊
  • Ultrasmall Solid Lipid Nanoparticles as a Potential Innovative Delivery System for a Drug Combination Against Glioma 🧠💉
  • Concanavalin A Grafted Nanoemulsions for Nasal Delivery: Preliminary Studies with Fluorescently Labelled Formulations 👃💡
  • Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases 🌿🧠
  • Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas 🧬💉
  • Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders 🔬🧠
  • Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models 🦴💊

 

 

Riham Elgogary | Pharmaceutics | Best Researcher Award

Assoc Prof Dr Riham Elgogary | Pharmaceutics | Best Researcher Award

Assoc Prof Dr Riham Elgogary, Faculty of pharmacy, ain shams university, Egypt

Dr. Riham El-Gogary is an Associate Professor of Pharmaceutics at Ain Shams University’s Faculty of Pharmacy. With extensive experience in pharmaceutical sciences, Dr. El-Gogary has significantly contributed to the field through research and teaching. Her work focuses on advanced drug delivery systems and nanotechnology applications in pharmacology. An active participant in academic and professional circles, she has been recognized for her dedication and excellence in both research and teaching. Her innovative research has led to numerous publications and awards, highlighting her role as a leading figure in pharmaceutics.

Publication Profile

Google Scholar

Strengths for the Award

  1. Strong Academic Background:
    • PhD in Pharmaceutical Sciences (Pharmaceutics) and substantial teaching experience in both undergraduate and postgraduate programs.
  2. Research Expertise:
    • Extensive research contributions in the field of pharmaceutics, including novel drug delivery systems and targeted therapies.
    • High-impact publications in reputable journals such as ACS Nano, Small, and Scientific Reports, indicating significant contributions to pharmaceutical sciences.
  3. Awards and Recognition:
    • Multiple international and national awards for publishing and teaching excellence, including the International Publishing Award from Ain Shams University and travel grants for conferences.
    • Recognition from professional bodies, such as the Egyptian Pharmacist Syndicate.
  4. Grants and Funding:
    • Successfully secured various grants, including research funding from the Missions Department, TWAS/Biovision, and AGYA, demonstrating the ability to attract competitive research funding.
  5. Professional Experience:
    • Active participation in professional committees and involvement in research supervision and practical course preparation, showcasing a well-rounded professional profile.

Areas for Improvement

  1. Publication Metrics:
    • While the researcher has numerous publications, improving the citation impact of some papers could further strengthen their profile. The impact of recent publications such as “Nose-to-brain delivery of 18β-Glycyrrhetinic acid” and “Development and in Vitro/In Vivo Evaluation of Itopride Hydrochloride Expanding Tablets” might be lower, and enhancing their visibility could be beneficial.
  2. Broader Research Impact:
    • Expanding research to include interdisciplinary collaborations or high-impact, emerging areas in pharmaceutics might increase their research visibility and influence.
  3. Leadership and Innovation:
    • Demonstrating leadership in groundbreaking research projects or innovations in pharmaceutics could enhance their candidacy. Engaging in high-profile research initiatives or leading large-scale research collaborations might be advantageous.

Education

Dr. Riham El-Gogary earned her PhD in Pharmaceutical Sciences (Pharmaceutics) from Ain Shams University in August 2014. She completed her M.Sc. in Pharmaceutical Sciences (Pharmaceutics) at the same institution in September 2010. Dr. El-Gogary holds a B.Sc. in Pharmaceutical Sciences from Ain Shams University, awarded in June 2004 with a general grade of “Excellent with Honors.” Her educational foundation is complemented by a diploma from Ramses College for Girls, completed in June 1999.

Experience

Dr. El-Gogary has been an Associate Professor of Pharmaceutics at Ain Shams University since December 2019. Her teaching repertoire includes Physical Pharmacy, Pharmaceutics, Biopharmaceutics, and Dosage Form Design for undergraduates and specialized Pharmaceutics for postgraduates. She has also taught part-time at Misr International University and the British University in Egypt. Additionally, she supervises student research projects and has contributed to the development of practical course materials. Her involvement extends to various committees and professional activities, including disaster management and health and safety.

Awards and Honors

Dr. El-Gogary has received several prestigious awards, including the International Publishing Award from Ain Shams University for multiple years and a Certificate of Excellence in Teaching Pharmaceutics. She was recognized with a partial travel award for conferences in the UK and Spain and received the Armor of Excellence from the Egyptian Pharmacist Syndicate in 2010. Her contributions to faculty accreditation and medical convoys have also been acknowledged with certificates of honor.

Research Focus

Dr. Riham El-Gogary’s research focuses on innovative drug delivery systems, particularly using nanotechnology. Her work includes the development of polymeric nanocapsules for targeted drug delivery, improving therapeutic efficacy for conditions such as cancer and psoriasis. She explores novel formulations like nanoemulgels and micelle-core/chitosan-shell systems. Her research aims to enhance the bioavailability and effectiveness of pharmaceutical agents, addressing significant challenges in drug delivery and therapeutic applications.

Publication Top Notes

  1. Polyethylene Glycol Conjugated Polymeric Nanocapsules for Targeted Delivery of Quercetin to Folate-Expressing Cancer Cells in Vitro and in Vivo – ACS Nano 8 (2), 1384-1401, 2014
  2. Passively Targeted Curcumin-Loaded Pegylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo – Small 11 (36), 4704-4722, 2015
  3. Triple-Modal Imaging of Magnetically-Targeted Nanocapsules in Solid Tumours In Vivo – Theranostics 6 (3), 342, 2016
  4. Polymeric Nanocapsular Baicalin: Chemometric Optimization, Physicochemical Characterization and Mechanistic Anticancer Approaches on Breast Cancer Cell Lines – Scientific Reports 9 (1), 11064, 2019
  5. Novel Antipsoriatic Fluidized Spanlastic Nanovesicles: In Vitro Physicochemical Characterization, Ex Vivo Cutaneous Retention and Exploratory Clinical Therapeutic Efficacy – International Journal of Pharmaceutics 568, 118556, 2019
  6. Fabrication of Rosuvastatin-Loaded Polymeric Nanocapsules: A Promising Modality for Treating Hepatic Cancer Delineated by Apoptotic and Cell Cycle Arrest Assessment – Drug Development and Industrial Pharmacy 45 (1), 55-62, 2019
  7. Ferulic Acid Nanocapsules as a Promising Treatment Modality for Colorectal Cancer: Preparation and In Vitro/In Vivo Appraisal – Life Sciences 298, 120500, 2022
  8. The Beneficial Activity of Curcumin and Resveratrol Loaded in Nanoemulgel for Healing of Burn-Induced Wounds – Journal of Drug Delivery Science and Technology 62, 102360, 2021
  9. Intra-Articular Multifunctional Celecoxib Loaded Hyaluronan Nanocapsules for the Suppression of Inflammation in an Osteoarthritic Rat Model – International Journal of Pharmaceutics 583, 119378, 2020
  10. Angiogenesis and Collagen Promoting Nutraceutical-Loaded Nanovesicles for Wound Healing – Journal of Drug Delivery Science and Technology 56, 101548, 2020

Conclusion

The candidate is highly suitable for the Research for Best Researcher Award due to their strong academic background, substantial research contributions, and recognition in their field. Their extensive publication record, successful acquisition of research grants, and involvement in professional committees showcase their dedication and impact in pharmaceutical sciences. Addressing areas for improvement, such as increasing the citation impact of their work and pursuing interdisciplinary research opportunities, could further bolster their candidacy. Overall, the candidate’s profile aligns well with the award’s criteria, making them a strong contender for the Research for Best Researcher Award.

 

 

Radha Goel | Pharmacy | Best Researcher Award

Dr Radha Goel | Pharmacy | Best Researcher Award

Dr Radha Goel, Lloyd Institute of Management and Technology, India

Dr. Radha Goel is a distinguished professor in the field of pharmacology with extensive experience in teaching, research, and administration. She is currently a Professor at Lloyd Institute of Management and Technology, Greater Noida. With a Doctorate in Pharmacology from Jaipur National University and over 15 years in academia, Dr. Goel is known for her dedication to advancing pharmaceutical sciences. She has received accolades such as the Best Teacher Excellence Award from Dr. A.P.J. Abdul Kalam University, highlighting her commitment to both student growth and academic excellence.

Strengths for the Award

Dr. Radha Goel demonstrates significant expertise in pharmacology, as evidenced by her extensive publication record, including first and corresponding author roles in high-impact journals. Her research focuses on neuropathic pain, epilepsy, and pharmacotherapeutics, with numerous contributions to the scientific community. Additionally, her leadership in academia, serving as a professor, editorial board member, and organizer of national seminars, highlights her commitment to advancing both research and education. The recognition she has received, such as the Best Teacher Excellence Award, further solidifies her standing as a distinguished researcher and educator.

Areas for Improvement

While Dr. Goel has an impressive publication portfolio, a more diverse range of research projects, including interdisciplinary collaborations, could enhance her impact. Additionally, securing more significant research grants and leading larger-scale, multi-institutional studies could further bolster her research profile. Increasing her international collaborations and presence in global conferences might also expand her influence in the broader scientific community.

Education

Dr. Radha Goel holds a Doctorate in Pharmacology from Jaipur National University and a Master’s degree in Pharmacology from Hamdard University, New Delhi. She completed her Post Graduate Diploma in Clinical Research at IGMPI, Gurgaon, and a Bachelor of Pharmacy at Hamdard University. Her foundational education includes a high school diploma from D.A.V Public School and Vidya Mandir Sr. Sec. School in Faridabad, setting the stage for her distinguished career in pharmacology.

Experience

Dr. Radha Goel has a robust academic career spanning over 15 years, including roles as Professor, Associate Professor, and Assistant Professor across various institutions like Lloyd Institute of Management and Technology and Institute of Technology and Science. Her experience includes working as a Clinical Research Associate and Lecturer, showcasing her expertise in both educational and research settings. Dr. Goel’s roles have involved curriculum development, research supervision, and administrative responsibilities, reflecting her comprehensive engagement in academia.

Awards and Honors

Dr. Radha Goel has been honored with the Best Teacher Excellence Award by Dr. A.P.J. Abdul Kalam University, recognizing her outstanding contributions to education. She has also been selected as a Central Controller for UPSEE Examination and has served as an Assistant Center Superintendent. Her achievements include a Publication Award and being a member of various organizing and scientific committees, demonstrating her commitment to advancing pharmaceutical sciences and education.

Research Focus

Dr. Radha Goel’s research focuses on drug development and neuropharmacology, particularly in neuropathic pain and diabetic neuropathy. Her work includes the nanoencapsulation of therapeutic agents and phytosome-based drug delivery systems. Recent projects explore the protective effects of plant extracts and the development of novel therapeutic strategies. Dr. Goel’s research is aimed at advancing understanding and treatment options for neurological and chronic pain disorders.

Publication Top Notes

Therapeutic Uses of Euphorbia thymifolia: A Review’

Influence of nebivolol on anticonvulsant effect of lamotrigine

Effect of daidzein on Parkinson disease induced by reserpine in rats

Potential contribution of antioxidant mechanism in the defensive effect of lycopene against partial sciatic nerve ligation induced behavioral, biochemical and histopathological …

Influence of carvedilol on anticonvulsant effect of gabapentin.

Neuropathic Pain-An Enervating Disease

Models for neuropathic pain: a review

Effect of nebivolol on anticonvulsant property of sodium valproate along with neuropharmacological benefits in rodents models of epilepsy and behaviour in mice

 

Conclusion

Dr. Radha Goel is a strong candidate for the Best Researcher Award, given her substantial contributions to pharmacology research and education. Her leadership roles and consistent publication record showcase her as a dedicated and impactful researcher. With further expansion into interdisciplinary and international research, she could enhance her already impressive career and strengthen her candidacy for prestigious research awards.